224 related articles for article (PubMed ID: 15491815)
1. Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes.
Chambers E; Mitragotri S
J Control Release; 2004 Nov; 100(1):111-9. PubMed ID: 15491815
[TBL] [Abstract][Full Text] [Related]
2. Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation.
Chambers E; Mitragotri S
Exp Biol Med (Maywood); 2007 Jul; 232(7):958-66. PubMed ID: 17609513
[TBL] [Abstract][Full Text] [Related]
3. Adsorption of amphiphilic hyperbranched polyglycerol derivatives onto human red blood cells.
Liu Z; Janzen J; Brooks DE
Biomaterials; 2010 Apr; 31(12):3364-73. PubMed ID: 20122720
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles disguised as red blood cells to evade the immune system.
Fang RH; Hu CM; Zhang L
Expert Opin Biol Ther; 2012 Apr; 12(4):385-9. PubMed ID: 22332936
[TBL] [Abstract][Full Text] [Related]
5. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.
Owens DE; Peppas NA
Int J Pharm; 2006 Jan; 307(1):93-102. PubMed ID: 16303268
[TBL] [Abstract][Full Text] [Related]
6. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.
Shenoy DB; Amiji MM
Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
Gaumet M; Vargas A; Gurny R; Delie F
Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
[TBL] [Abstract][Full Text] [Related]
8. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
9. Erythrocytes load of low molecular weight chitosan nanoparticles as a potential vascular drug delivery system.
Fan W; Yan W; Xu Z; Ni H
Colloids Surf B Biointerfaces; 2012 Jun; 95():258-65. PubMed ID: 22469561
[TBL] [Abstract][Full Text] [Related]
10. Nanosize and surface charge effects of hydroxyapatite nanoparticles on red blood cell suspensions.
Han Y; Wang X; Dai H; Li S
ACS Appl Mater Interfaces; 2012 Sep; 4(9):4616-22. PubMed ID: 22860897
[TBL] [Abstract][Full Text] [Related]
11. Transmucosal macromolecular drug delivery.
Prego C; García M; Torres D; Alonso MJ
J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
[TBL] [Abstract][Full Text] [Related]
12. Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies.
Bhateria M; Rachumallu R; Singh R; Bhatta RS
Expert Opin Drug Deliv; 2014 Aug; 11(8):1219-36. PubMed ID: 24912015
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of nanoparticles within polymeric pores for controlled release of drug.
Asif M; Arayne MS; Sultana N; Hussain F
Pak J Pharm Sci; 2006 Jan; 19(1):73-84. PubMed ID: 16632458
[TBL] [Abstract][Full Text] [Related]
14. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone.
Choi SW; Kim JH
J Control Release; 2007 Sep; 122(1):24-30. PubMed ID: 17628158
[TBL] [Abstract][Full Text] [Related]
15. In vivo circulation, clearance, and biodistribution of polyglycerol grafted functional red blood cells.
Chapanian R; Constantinescu I; Brooks DE; Scott MD; Kizhakkedathu JN
Biomaterials; 2012 Apr; 33(10):3047-57. PubMed ID: 22261097
[TBL] [Abstract][Full Text] [Related]
16. Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles.
Tröster SD; Kreuter J
J Microencapsul; 1992; 9(1):19-28. PubMed ID: 1613640
[TBL] [Abstract][Full Text] [Related]
17. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles.
He X; Nie H; Wang K; Tan W; Wu X; Zhang P
Anal Chem; 2008 Dec; 80(24):9597-603. PubMed ID: 19007246
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation.
Khandelwal S; van Rooijen N; Saxena RK
Transfusion; 2007 Sep; 47(9):1725-32. PubMed ID: 17725740
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled drug delivery systems. 1. Properties and in vitro/in vivo behavior of acyclovir self-assembled nanoparticles (SAN).
Jin Y; Tong L; Ai P; Li M; Hou X
Int J Pharm; 2006 Feb; 309(1-2):199-207. PubMed ID: 16377106
[TBL] [Abstract][Full Text] [Related]
20. Modification of single walled carbon nanotube surface chemistry to improve aqueous solubility and enhance cellular interactions.
Crouzier T; Nimmagadda A; Nollert MU; McFetridge PS
Langmuir; 2008 Nov; 24(22):13173-81. PubMed ID: 18947245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
